| Year |
Citation |
Score |
| 2024 |
Benoit A, Abraham MJ, Li S, Kim J, Estrada-Tejedor R, Bakadlag R, Subramaniam N, Makhani K, Guilbert C, Tu R, Salaciak M, Klein KO, Coyle KM, Hilton LK, Santiago R, ... ... Morin RD, et al. STAT6 mutations enriched at diffuse large B-cell lymphoma relapse reshape the tumor microenvironment. International Journal of Hematology. PMID 38285120 DOI: 10.1007/s12185-023-03692-x |
0.77 |
|
| 2023 |
Hilton LK, Scott DW, Morin RD. Biological heterogeneity in diffuse large B-cell lymphoma. Seminars in Hematology. PMID 38151380 DOI: 10.1053/j.seminhematol.2023.11.006 |
0.761 |
|
| 2023 |
Sircar A, Singh S, Xu-Monette ZY, Coyle KM, Hilton LK, Chavdoula E, Ranganathan P, Jain N, Hanel W, Tsichlis P, Alinari L, Peterson BR, Tao J, Muthusamy N, Baiocchi R, ... ... Morin R, et al. Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphoma. Leukemia. PMID 37598282 DOI: 10.1038/s41375-023-02006-8 |
0.724 |
|
| 2023 |
Davies JR, Hilton LK, Jiang A, Barrans SL, Burton C, Johnson PWM, Davies AJ, Du MQ, Tooze RM, Cucco F, Care MA, Morin RD, Steidl C, Sha C, Westhead DR, et al. Comparison of MHG and DZsig reveals shared biology and a core overlap group with inferior prognosis in DLBCL. Blood Advances. PMID 37595057 DOI: 10.1182/bloodadvances.2023010673 |
0.664 |
|
| 2023 |
Hilton LK, Ngu HS, Collinge B, Dreval K, Ben-Neriah S, Rushton CK, Wong JCH, Cruz M, Roth A, Boyle M, Meissner B, Slack GW, Farinha P, Craig JW, Gerrie AS, ... ... Morin RD, et al. Relapse Timing Is Associated With Distinct Evolutionary Dynamics in Diffuse Large B-Cell Lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2300570. PMID 37319384 DOI: 10.1200/JCO.23.00570 |
0.813 |
|
| 2023 |
Dreval K, Hilton LK, Cruz M, Shaalan H, Ben-Neriah S, Boyle M, Collinge BJ, Coyle KM, Duns G, Farinha P, Grande B, Meissner B, Pararajalingam P, Rushton CK, Slack GW, ... ... Morin RD, et al. Genetic Subdivisions of Follicular Lymphoma Defined by Distinct Coding and non-coding Mutation Patterns. Blood. PMID 37084389 DOI: 10.1182/blood.2022018719 |
0.817 |
|
| 2023 |
Hilton LK, Ngu HS, Collinge B, Dreval K, Ben-Neriah S, Rushton CK, Wong JCH, Cruz M, Roth A, Boyle M, Meissner B, Slack GW, Farinha P, Craig JW, Gerrie AS, ... ... Morin RD, et al. Relapse timing is associated with distinct evolutionary dynamics in DLBCL. Medrxiv : the Preprint Server For Health Sciences. PMID 36945587 DOI: 10.1101/2023.03.06.23286584 |
0.846 |
|
| 2022 |
Wang X, Nissen M, Gracias D, Kusakabe M, Simkin G, Jiang A, Duns G, Sarkozy C, Hilton L, Chavez EA, Segat GC, Wong R, Kim J, Aoki T, Islam R, ... ... Morin RD, et al. Single-cell profiling reveals a memory B cell-like subtype of follicular lymphoma with increased transformation risk. Nature Communications. 13: 6772. PMID 36351924 DOI: 10.1038/s41467-022-34408-0 |
0.749 |
|
| 2022 |
Rushton CK, Dreval K, Morin RD. Concerning data inconsistencies in Burkitt lymphoma genome study. Blood. PMID 36302254 DOI: 10.1182/blood.2022016505 |
0.75 |
|
| 2022 |
Alduaij W, Collinge BJ, Ben-Neriah S, Jiang A, Hilton LK, Boyle M, Meissner B, Chong LC, Miyata-Takata T, Slack GW, Farinha P, Craig JW, Lytle A, Savage KJ, Villa D, ... ... Morin RD, et al. Molecular Determinants of Clinical Outcomes In a Real-World Diffuse Large B-cell Lymphoma Population. Blood. PMID 36302166 DOI: 10.1182/blood.2022018248 |
0.738 |
|
| 2022 |
Bal E, Kumar R, Hadigol M, Holmes AB, Hilton LK, Loh JW, Dreval K, Wong JCH, Vlasevska S, Corinaldesi C, Soni RK, Basso K, Morin RD, Khiabanian H, Pasqualucci L, et al. Author Correction: Super-enhancer hypermutation alters oncogene expression in B cell lymphoma. Nature. PMID 36253470 DOI: 10.1038/s41586-022-05285-w |
0.717 |
|
| 2022 |
Dreval K, Boutros PC, Morin RD. Minimum Information for Reporting a Genomics Experiment. Blood. PMID 36219881 DOI: 10.1182/blood.2022016095 |
0.33 |
|
| 2022 |
Thomas N, Dreval K, Gerhard DS, Hilton LK, Abramson JS, Barta SK, Bartlett NL, Bethony J, Bhatia K, Bowen J, Bryan AC, Cesarman E, Casper C, Cruz M, Dyer M, ... ... Morin RD, et al. GENETIC SUBGROUPS INFORM ON PATHOBIOLOGY IN ADULT AND PEDIATRIC BURKITT LYMPHOMA. Blood. PMID 36201743 DOI: 10.1182/blood.2022016534 |
0.839 |
|
| 2022 |
Freeman CL, Pararajalingam P, Jin L, Balasubramanian S, Jiang A, Xu W, Grau M, Zapukhlyak M, Boyle M, Hodkinson B, Schaffer M, Enny C, Deshpande S, Sun S, Vermeulen J, ... Morin RD, et al. Molecular determinants of outcomes in relapsed or refractory mantle cell lymphoma treated with ibrutinib or temsirolimus in the MCL3001 (RAY) trial. Leukemia. PMID 35963941 DOI: 10.1038/s41375-022-01658-2 |
0.325 |
|
| 2022 |
Bal E, Kumar R, Hadigol M, Holmes AB, Hilton LK, Loh JW, Dreval K, Wong JCH, Vlasevska S, Corinaldesi C, Soni RK, Basso K, Morin RD, Khiabanian H, Pasqualucci L, et al. Super-enhancer hypermutation alters oncogene expression in B cell lymphoma. Nature. PMID 35794478 DOI: 10.1038/s41586-022-04906-8 |
0.776 |
|
| 2022 |
Xia M, David L, Teater M, Gutierrez J, Wang X, Meydan C, Lytle A, Slack GW, Scott DW, Morin RD, Onder O, Elenitoba-Johnson KSJ, Zamponi N, Cerchietti L, Lu T, et al. BCL10 mutations define distinct dependencies guiding precision therapy for DLBCL. Cancer Discovery. PMID 35658124 DOI: 10.1158/2159-8290.CD-21-1566 |
0.309 |
|
| 2022 |
Dodani DD, Nguyen MH, Morin RD, Marra MA, Corbett RD. Combinatorial and Machine Learning Approaches for Improved Somatic Variant Calling From Formalin-Fixed Paraffin-Embedded Genome Sequence Data. Frontiers in Genetics. 13: 834764. PMID 35571031 DOI: 10.3389/fgene.2022.834764 |
0.416 |
|
| 2022 |
Coyle KM, Hillman T, Cheung M, Grande B, Bushell KR, Arthur SE, Alcaide M, Thomas N, Dreval K, Wong S, Campbell K, Morin RD. Shared and distinct genetic features in human and canine B-cell lymphomas. Blood Advances. PMID 35359007 DOI: 10.1182/bloodadvances.2021006429 |
0.79 |
|
| 2022 |
Lavoie JM, Alcaide M, Fisher RA, Seckl MJ, Morin R, Tinker AV. Targeted Error-Suppressed Detection of Circulating Paternal DNA to Establish a Diagnosis of Gestational Trophoblastic Neoplasm. Jco Precision Oncology. 1: 1-6. PMID 35172520 DOI: 10.1200/PO.17.00154 |
0.648 |
|
| 2022 |
Benoit A, Bou-Petit E, Chou H, Lu M, Guilbert C, Luo VM, Assouline S, Morin RD, Dmitrienko S, Estrada-Tejedor R, Johnson NA, Mann KK. Mutated RAS-associating proteins and ERK activation in relapse/refractory diffuse large B cell lymphoma. Scientific Reports. 12: 779. PMID 35039569 DOI: 10.1038/s41598-021-04736-0 |
0.354 |
|
| 2021 |
Morin J, Royle TCA, Zhang H, Speller C, Alcaide M, Morin R, Ritchie M, Cannon A, George M, George M, Yang D. Indigenous sex-selective salmon harvesting demonstrates pre-contact marine resource management in Burrard Inlet, British Columbia, Canada. Scientific Reports. 11: 21160. PMID 34759290 DOI: 10.1038/s41598-021-00154-4 |
0.62 |
|
| 2021 |
Yang KC, Kalloger SE, Aird JJ, Lee MKC, Rushton C, Mungall KL, Mungall AJ, Gao D, Chow C, Xu J, Karasinska JM, Colborne S, Jones SJM, Schrader J, Morin RD, et al. Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasms. Cell Reports. 37: 109817. PMID 34644566 DOI: 10.1016/j.celrep.2021.109817 |
0.794 |
|
| 2021 |
Pighi C, Cheong TC, Compagno M, Patrucco E, Arigoni M, Olivero M, Wang Q, López C, Bernhart SH, Grande BM, Poggio T, Langellotto F, Bonello L, Dall'Olio R, Martínez-Martín S, ... ... Morin RD, et al. Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphoma. Blood Advances. 5: 5239-5257. PMID 34625792 DOI: 10.1182/bloodadvances.2021005682 |
0.785 |
|
| 2021 |
Morin RD, Arthur SE, Hodson DJ. Molecular profiling in diffuse large B-cell lymphoma: why so many types of subtypes? British Journal of Haematology. PMID 34467527 DOI: 10.1111/bjh.17811 |
0.806 |
|
| 2021 |
Nowicka M, Hilton LK, Ashton-Key M, Hargreaves CE, Lee C, Foxall R, Carter MJ, Beers SA, Potter KN, Bolen CR, Klein C, Knapp A, Mir F, Rose-Zerilli M, Burton C, ... ... Morin RD, et al. Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment. Blood Advances. 5: 2945-2957. PMID 34323958 DOI: 10.1182/bloodadvances.2021004770 |
0.779 |
|
| 2021 |
Morin RD, Arthur SE, Assouline S. Treating lymphoma is now a bit EZ-er. Blood Advances. 5: 2256-2263. PMID 33904892 DOI: 10.1182/bloodadvances.2020002773 |
0.813 |
|
| 2021 |
Duns G, Viganò E, Ennishi D, Sarkozy C, Hung SS, Chavez EA, Takata K, Rushton C, Jiang A, Ben-Neriah S, Woolcock B, Slack GW, Hsi ED, Craig JW, Hilton LK, ... ... Morin RD, et al. Characterization of DLBCL with a PMBL gene expression signature. Blood. PMID 33684939 DOI: 10.1182/blood.2020007683 |
0.846 |
|
| 2020 |
Jiang A, Hilton LK, Tang J, Rushton CK, Grande BM, Scott DW, Morin RD. PRPS-ST: A protocol-agnostic self-training method for gene expression-based classification of blood cancers. Blood Cancer Discovery. 1: 244-257. PMID 33392514 DOI: 10.1158/2643-3230.BCD-20-0076 |
0.788 |
|
| 2020 |
Collinge BJ, Ben-Neriah S, Chong LC, Boyle M, Jiang A, Miyata-Takata T, Farinha P, Craig JW, Slack GW, Ennishi D, Mottok A, Meissner B, Chavez EA, Gerrie AS, Villa D, ... ... Morin RD, et al. Impact of MYC and BCL2 structural variants in tumors of DLBCL morphology and mechanisms of false-negative MYC IHC. Blood. PMID 33120427 DOI: 10.1182/blood.2020007193 |
0.507 |
|
| 2020 |
Isaev K, Ennishi D, Hilton L, Skinnider B, Mungall KL, Mungall AJ, Bakhtiari M, Tremblay-LeMay R, Silva A, Ben-Neriah S, Boyle M, Villa D, Marra MA, Steidl C, Gascoyne RD, ... Morin R, et al. Molecular Attributes Underlying Central Nervous System and Systemic Relapse in Diffuse Large B-cell Lymphoma. Haematologica. PMID 32817292 DOI: 10.3324/Haematol.2020.255950 |
0.762 |
|
| 2020 |
Alcaide M, Cheung M, Hillman J, Rassekh SR, Deyell RJ, Batist G, Karsan A, Wyatt AW, Johnson N, Scott DW, Morin RD. Evaluating the quantity, quality and size distribution of cell-free DNA by multiplex droplet digital PCR. Scientific Reports. 10: 12564. PMID 32724107 DOI: 10.1038/S41598-020-69432-X |
0.703 |
|
| 2020 |
Nadeu F, Mas-de-Les-Valls R, Navarro A, Royo R, Martín S, Villamor N, Suárez-Cisneros H, Mares R, Lu J, Enjuanes A, Rivas-Delgado A, Aymerich M, Baumann T, Colomer D, Delgado J, ... Morin RD, et al. IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasms. Nature Communications. 11: 3390. PMID 32636395 DOI: 10.1038/S41467-020-17095-7 |
0.451 |
|
| 2020 |
Venturutti L, Teater M, Zhai A, Chadburn A, Babiker L, Kim D, Béguelin W, Lee TC, Kim Y, Chin CR, Yewdell WT, Raught B, Phillip JM, Jiang Y, Staudt LM, ... ... Morin RD, et al. TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory Fate. Cell. PMID 32619424 DOI: 10.1016/J.Cell.2020.05.049 |
0.445 |
|
| 2020 |
Rushton CK, Arthur SE, Alcaide M, Cheung M, Jiang A, Coyle KM, Cleary KLS, Thomas N, Hilton LK, Michaud N, Daigle S, Davidson J, Bushell K, Yu S, Rys RN, ... ... Morin RD, et al. Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma. Blood Advances. 4: 2886-2898. PMID 32589730 DOI: 10.1182/Bloodadvances.2020001696 |
0.823 |
|
| 2020 |
Morin RD, Scott DW. DLBCL subclassification: divide and conquer? Blood. 135: 1722-1724. PMID 32407529 DOI: 10.1182/Blood.2020005335 |
0.355 |
|
| 2020 |
Wright GW, Huang DW, Phelan JD, Coulibaly ZA, Roulland S, Young RM, Wang JQ, Schmitz R, Morin RD, Tang J, Jiang A, Bagaev A, Plotnikova O, Kotlov N, Johnson CA, et al. A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications. Cancer Cell. 37: 551-568.e14. PMID 32289277 DOI: 10.1016/J.Ccell.2020.03.015 |
0.42 |
|
| 2020 |
Pararajalingam P, Coyle KM, Arthur S, Thomas N, Alcaide M, Meissner B, Boyle M, Qureshi Q, Grande BM, Rushton C, Slack GW, Mungall A, Tam C, Agarwal R, Dawson SJ, ... ... Morin RD, et al. Coding and non-coding drivers of mantle cell lymphoma identified through exome and genome sequencing. Blood. PMID 32160292 DOI: 10.1182/Blood.2019002385 |
0.84 |
|
| 2020 |
Mendis S, Alcaide M, Topham JT, Johnson B, Morin RD, Chu J, Bosdet I, Kopetz S, Karsan A, Gill S, Laskin J, Jones SJM, Marra MA, Schaeffer DF, Renouf DJ, et al. Integration of Whole-Genome Sequencing With Circulating Tumor DNA Analysis Captures Clonal Evolution and Tumor Heterogeneity in Non-V600 BRAF Mutant Colorectal Cancer. Clinical Colorectal Cancer. PMID 32151517 DOI: 10.1016/J.Clcc.2020.02.001 |
0.812 |
|
| 2020 |
Ennishi D, Healy S, Bashashati A, Saberi S, Hother C, Mottok A, Chan FC, Chong L, Abraham L, Kridel R, Boyle M, Meissner B, Aoki T, Takata K, Woolcock BW, ... ... Morin RD, et al. TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma. Nature Medicine. PMID 32094924 DOI: 10.1038/S41591-020-0757-Z |
0.833 |
|
| 2020 |
Rushton C, Alcaide M, Cheung M, Michaud NR, Daigle S, Rys RN, Arthur SE, Zrymiak M, Davidson J, Bushell KR, Yu S, Jain MD, Shepherd LE, Marra MA, Kuruvilla J, ... ... Morin RD, et al. The Copy Number Landscape of Relapsed and Refractory Diffuse Large B-Cell Lymphoma Blood. 136: 8-9. DOI: 10.1182/blood-2020-142871 |
0.487 |
|
| 2020 |
Coyle KM, Qureshi Q, Pararajalingam P, Thomas N, Audas TE, Morin RD. Perturbations in HNRNPH1 Splicing and Abundance Affect Global Splicing and Proliferation in Mantle Cell Lymphoma Blood. 136: 23-24. DOI: 10.1182/BLOOD-2020-141389 |
0.342 |
|
| 2020 |
Arthur SE, Thomas N, Rushton C, Tang J, Alcaide M, Healy S, Telenius A, Mottok A, Scott DW, Steidl C, Morin RD. Nfkbiz 3′ UTR Mutations Confer Selective Growth Advantage and Affect Drug Response in Diffuse Large B-Cell Lymphoma Blood. 136: 31-31. DOI: 10.1182/blood-2020-137700 |
0.398 |
|
| 2019 |
Haile S, Corbett RD, Bilobram S, Mungall K, Grande BM, Kirk H, Pandoh P, MacLeod T, McDonald H, Bala M, Coope RJ, Moore RA, Mungall AJ, Zhao Y, Morin RD, et al. Evaluation of protocols for rRNA depletion-based RNA sequencing of nanogram inputs of mammalian total RNA. Plos One. 14: e0224578. PMID 31671154 DOI: 10.1371/Journal.Pone.0224578 |
0.737 |
|
| 2019 |
Hilton LK, Tang J, Ben-Neriah S, Alcaide M, Jiang A, Grande BM, Rushton CK, Boyle M, Meissner B, Scott DW, Morin RD. --The double hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH. Blood. PMID 31527075 DOI: 10.1182/Blood.2019002600 |
0.829 |
|
| 2019 |
Khakabimamaghani S, Malikic S, Tang J, Ding D, Morin R, Chindelevitch L, Ester M. Collaborative intra-tumor heterogeneity detection. Bioinformatics (Oxford, England). 35: i379-i388. PMID 31510674 DOI: 10.1093/Bioinformatics/Btz355 |
0.428 |
|
| 2019 |
Negri GL, Grande BM, Delaidelli A, El-Naggar A, Cochrane D, Lau CC, Triche TJ, Moore RA, Jones SJM, Montpetit A, Marra MA, Malkin D, Morin RD, Sorensen PH. Integrative genomic analysis of matched primary and metastatic pediatric osteosarcoma. The Journal of Pathology. PMID 31236944 DOI: 10.1002/Path.5319 |
0.814 |
|
| 2019 |
Shafaattalab S, Li AY, Lin E, Stevens CM, Dewar LJ, Lynn FC, Sanatani S, Laksman Z, Morin RD, van Petegem F, Hove-Madsen L, Tieleman DP, Davis JP, Tibbits GF. In vitro analyses of suspected arrhythmogenic thin filament variants as a cause of sudden cardiac death in infants. Proceedings of the National Academy of Sciences of the United States of America. PMID 30886088 DOI: 10.1073/Pnas.1819023116 |
0.356 |
|
| 2019 |
Alcaide M, Rushton C, Morin RD. Ultrasensitive Detection of Circulating Tumor DNA in Lymphoma via Targeted Hybridization Capture and Deep Sequencing of Barcoded Libraries. Methods in Molecular Biology (Clifton, N.J.). 1956: 383-435. PMID 30779047 DOI: 10.1007/978-1-4939-9151-8_20 |
0.835 |
|
| 2019 |
Khakabimamaghani S, Kelkar YD, Grande BM, Morin RD, Ester M, Ziemek D. SUBSTRA: Supervised Bayesian Patient Stratification. Bioinformatics (Oxford, England). PMID 30768166 DOI: 10.1093/Bioinformatics/Btz112 |
0.71 |
|
| 2019 |
Pandoh PK, Corbett RD, McDonald H, Alcaide M, Kirk H, Trinh E, Haile S, MacLeod T, Smailus D, Bilobram S, Mungall AJ, Ma Y, Moore RA, Coope R, Zhao Y, ... ... Morin RD, et al. A high-throughput protocol for isolating cell-free circulating tumor DNA from peripheral blood. Biotechniques. 66: 85-92. PMID 30744412 DOI: 10.2144/Btn-2018-0148 |
0.751 |
|
| 2019 |
Ennishi D, Takata K, Beguelin W, Duns G, Mottok A, Farinha P, Bashashati A, Saberi S, Boyle M, Meissner B, Ben-Neriah S, Woolcock BW, Telenius A, Lai D, Teater M, ... ... Morin RD, et al. Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition. Cancer Discovery. PMID 30705065 DOI: 10.1158/2159-8290.Cd-18-1090 |
0.61 |
|
| 2019 |
Grande BM, Gerhard DS, Jiang A, Griner NB, Abramson JS, Alexander TB, Allen H, Ayers LW, Bethony JM, Bhatia K, Bowen J, Casper C, Choi JK, Culibrk L, Davidsen TM, ... ... Morin RD, et al. Genome-wide discovery of somatic coding and non-coding mutations in pediatric endemic and sporadic Burkitt lymphoma. Blood. PMID 30617194 DOI: 10.1182/Blood-2018-09-871418 |
0.849 |
|
| 2019 |
Duns G, Viganò E, Ennishi D, Sarkozy C, Hung S, Chavez E, Takata K, Mottok A, Gascoyne RD, Morin RD, Savage KJ, Scott DW, Steidl C. Diffuse Large B-Cell Lymphomas with a Molecular PMBCL Expression Signature Represent a Distinct Molecular Subtype Associated with Poor Clinical Outcome Blood. 134: 922-922. DOI: 10.1182/Blood-2019-131450 |
0.542 |
|
| 2019 |
Coyle KM, Pararajalingam P, Arthur SE, Thomas N, Alcaide M, Meissner B, Boyle M, Grande BM, Rushton C, Tooman L, Slack GW, Mungall AJ, Gascoyne RD, Steidl C, Connors JM, ... ... Morin RD, et al. Mutations Affecting RNA Binding Proteins Are a Novel Feature of Mantle Cell Lymphoma Blood. 134: 1478-1478. DOI: 10.1182/Blood-2019-129136 |
0.831 |
|
| 2019 |
Arthur SE, Thomas N, Rushton C, Alcaide M, Healy S, Mottok A, Scott DW, Steidl C, Morin RD. NFKBIZ3′ UTR Mutations Confer Selective Growth Advantage and Activate Genes with Therapeutic Implications in Diffuse Large B-Cell Lymphoma Blood. 134: 296-296. DOI: 10.1182/Blood-2019-127421 |
0.49 |
|
| 2019 |
Rushton C, Arthur SE, Alcaide M, Cheung M, Thomas N, Hilton LK, Michaud NR, Daigle S, Davidson J, Bushell KR, Yu S, Jain MD, Shepherd LE, Crump M, Mann KK, ... ... Morin RD, et al. Recurrent Patterns of Clonal Evolution in Relapsed-Refractory DLBCL Following Treatment with R-CHOP Blood. 134: 921-921. DOI: 10.1182/Blood-2019-127399 |
0.846 |
|
| 2019 |
Rys RN, Geoffrion D, Rushton C, Alcaide M, Santiago R, Mann KK, Dmitrienko S, Petrogiannis-Haliotis T, Assouline S, Morin RD, Johnson N. CD20 Is an Unstable Target in Primary-Refractory High-Grade Lymphomas Blood. 134: 1608-1608. DOI: 10.1182/Blood-2019-127129 |
0.363 |
|
| 2019 |
Farinha P, Ennishi D, Mottok A, Ben-Neriah S, Meissner B, Boyle M, Craig JW, Slack GW, Villa D, Savage KJ, Sehn LH, Morin RD, Marra MA, Connors JM, Gascoyne RD, et al. TP53 Expression Correlates with TP53 Mutations and Is an Independent Predictor of Clinical Outcome in Patients with DLBCL Treated with R-CHOP Blood. 134: 3964-3964. DOI: 10.1182/Blood-2019-121943 |
0.605 |
|
| 2019 |
Vigano E, Duns G, Ennishi D, Sarkozy C, Woolcock B, Cheung F, Chavez E, Hung SS, Takata K, Mottok A, Gascoyne R, Savage KJ, Morin R, Scott DW, Steidl C. Abstract 3765: Somatic JAK-STAT mutations in subtypes of aggressive B-cell lymphomas with DLBCL morphology Cancer Research. 79: 3765-3765. DOI: 10.1158/1538-7445.Sabcs18-3765 |
0.534 |
|
| 2019 |
Healy S, Ennishi D, Bashashati A, Saberi S, Hother C, Mottok A, Chan FC, Chong L, Kridel R, Boyle M, Meissner B, Aoki T, Takata K, Woolcock BW, Vigano E, ... ... Morin RD, et al. Abstract 3480:TMEM30Aloss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma Cancer Research. 79: 3480-3480. DOI: 10.1158/1538-7445.Am2019-3480 |
0.625 |
|
| 2019 |
Rushton C, Alcaide M, Cheung M, Thomas N, Arthur S, Michaud N, Daigle S, Davidson J, Bushell K, Yu S, Jain M, Shepherd L, Crump M, Mann K, Kuruvilla J, ... ... Morin R, et al. IDENTIFYING MUTATIONS ENRICHED IN RELAPSED-REFRACTORY DLBCL TO DERIVE GENETIC FACTORS UNDERLYING TREATMENT RESISTANCE Hematological Oncology. 37: 35-36. DOI: 10.1002/Hon.4_2629 |
0.81 |
|
| 2019 |
Arthur SE, Mottok A, Cojocaru R, Jiang A, Grande BM, Alcaide M, Rushton C, Ennishi D, Lat PK, Davidson J, Bushell KR, Audas T, Unrau P, Sen D, Gascoyne RD, ... ... Morin RD, et al. Functional Characterization Of Nfkbiz 3′ Utr Mutations In Diffuse Large B-Cell Lymphoma Hematological Oncology. 37: 74-75. DOI: 10.1002/Hon.43_2629 |
0.811 |
|
| 2019 |
Hilton L, Alcaide M, Ben-Neriah S, Jiang A, Grande B, Rushton C, Boyle M, Meissner B, Scott D, Morin R. CRYPTIC MYC
AND BCL2
REARRANGEMENTS ARE AMONG A RANGE OF GENETIC MECHANISMS UNDERLYING THE DOUBLE HIT SIGNATURE IN NON-DOUBLE HIT DIFFUSE LARGE B-CELL LYMPHOMA Hematological Oncology. 37: 73-74. DOI: 10.1002/Hon.42_2629 |
0.815 |
|
| 2018 |
Wong HL, Zhao EY, Jones MR, Reisle CR, Eirew P, Pleasance E, Grande BM, Karasinska JM, Kalloger SE, Lim HJ, Shen Y, Yip S, Morin RD, Laskin J, Marra MA, et al. Temporal Dynamics of Genomic Alterations in a Germline-Mutated Pancreatic Cancer With Low Genomic Instability Burden but Exceptional Response to Fluorouracil, Oxaliplatin, Leucovorin, and Irinotecan. Jco Precision Oncology. 2. PMID 32913994 DOI: 10.1200/PO.18.00057 |
0.765 |
|
| 2018 |
Ennishi D, Jiang A, Boyle M, Collinge B, Grande BM, Ben-Neriah S, Rushton C, Tang J, Thomas N, Slack GW, Farinha P, Takata K, Miyata-Takata T, Craig J, Mottok A, ... ... Morin RD, et al. Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1801583. PMID 30523716 DOI: 10.1200/Jco.18.01583 |
0.816 |
|
| 2018 |
Alcaide M, Cheung M, Bushell K, Arthur SE, Wong HL, Karasinska J, Renouf D, Schaeffer DF, McNamara S, Tertre MCD, Batist G, Kennecke HF, Karsan A, Morin RD. A Novel Multiplex droplet digital PCR Assay to Identify and Quantify KRAS Mutations in Clinical Specimens. The Journal of Molecular Diagnostics : Jmd. PMID 30472330 DOI: 10.1016/J.Jmoldx.2018.09.007 |
0.82 |
|
| 2018 |
Chong LC, Ben-Neriah S, Slack GW, Freeman C, Ennishi D, Mottok A, Collinge B, Abrisqueta P, Farinha P, Boyle M, Meissner B, Kridel R, Gerrie AS, Villa D, Savage KJ, ... ... Morin RD, et al. High-resolution architecture and partner genes of rearrangements in lymphoma with DLBCL morphology. Blood Advances. 2: 2755-2765. PMID 30348671 DOI: 10.1182/Bloodadvances.2018023572 |
0.574 |
|
| 2018 |
Arthur SE, Jiang A, Grande BM, Alcaide M, Cojocaru R, Rushton CK, Mottok A, Hilton LK, Lat PK, Zhao EY, Culibrk L, Ennishi D, Jessa S, Chong L, Thomas N, ... ... Morin RD, et al. Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma. Nature Communications. 9: 4001. PMID 30275490 DOI: 10.1038/S41467-018-06354-3 |
0.832 |
|
| 2018 |
Alcaide M, Morin RD. Novel Multiplexing Strategies for Quantification of Rare Alleles Using ddPCR. Methods in Molecular Biology (Clifton, N.J.). 1768: 275-301. PMID 29717449 DOI: 10.1007/978-1-4939-7778-9_16 |
0.7 |
|
| 2018 |
Zaja F, Salvi F, Rossi M, Sabattini E, Evangelista A, Ciccone G, Angelucci E, Gaidano G, Zanni M, Ladetto M, Chiappella A, Vitolo U, Zinzani PL, Califano C, Tucci A, ... ... Morin R, et al. Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi. Leukemia & Lymphoma. 1-7. PMID 29616865 DOI: 10.1080/10428194.2018.1452208 |
0.818 |
|
| 2018 |
Rey K, Manku S, Enns W, Van Rossum T, Bushell K, Morin RD, Brinkman FSL, Choy JC. Disruption of the Gut Microbiota With Antibiotics Exacerbates Acute Vascular Rejection. Transplantation. PMID 29538261 DOI: 10.1097/Tp.0000000000002169 |
0.742 |
|
| 2018 |
Wever CM, Geoffrion D, Grande BM, Yu S, Alcaide M, Lemaire M, Riazalhosseini Y, Hébert J, Gavino C, Vinh DC, Petrogiannis-Haliotis T, Dmitrienko S, Mann KK, Morin RD, Johnson NA. The genomic landscape of two Burkitt lymphoma cases and derived cell lines: comparison between primary and relapse samples. Leukemia & Lymphoma. 1-16. PMID 29295643 DOI: 10.1080/10428194.2017.1413186 |
0.841 |
|
| 2018 |
Kutovaya O, Hung S, Viganò E, Telenius A, Woolcock BW, Meissner B, Colborne S, Gascoyne RD, Villa D, Morin RD, Scott DW, Morin GB, Steidl C. UBR5 Mutations in Mantle Cell Lymphoma Lead to Increased Proliferation through a Cyclin D1-Dependent Mechanism Blood. 132: 2849-2849. DOI: 10.1182/Blood-2018-99-118524 |
0.518 |
|
| 2018 |
Jain MD, Morin RD, Prica A, Kukreti V, Kridel R, Laister RC, Meng L, Rushton C, Alcaide M, Goswami RS, Delabie JM, Weiss J, Panzarella T, Crump M, Scott DW, et al. Obinutuzumab Plus Gemcitabine, Dexamethasone and Cisplatin (O-GDP) As Salvage Chemotherapy Prior to Autologous Stem Cell Transplant in Aggressive B Cell Lymphoma Blood. 132: 4610-4610. DOI: 10.1182/Blood-2018-99-117333 |
0.328 |
|
| 2018 |
Ennishi D, Jiang A, Boyle M, Collinge B, Grande BM, Ben-Neriah S, Slack GW, Farinha P, Villa D, Mottok A, Meissner B, Saberi S, Bashashati A, Savage KJ, Sehn LH, ... ... Morin RD, et al. The Double-Hit Gene Expression Signature Defines a Clinically and Biologically Distinct Subgroup within GCB-DLBCL Blood. 132: 921-921. DOI: 10.1182/Blood-2018-99-116827 |
0.807 |
|
| 2018 |
Ennishi D, Takata K, Béguelin W, Duns G, Mottok A, Farinha P, Bashashati A, Scott D, Boyle M, Meissner B, Ben-Neriah S, Woolcock BW, Telenius A, Lai D, Teater MR, ... ... Morin RD, et al. Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 As a Therapeutic Target for Restoring MHC Expression in Diffuse Large B-Cell Lymphoma Blood. 132: 1560-1560. DOI: 10.1182/Blood-2018-99-112010 |
0.566 |
|
| 2018 |
Viganò E, Duns G, Ennishi D, Gascoyne RD, Morin RD, Scott DW, Steidl C. Recurrent IL4R Somatic Mutations in Diffuse Large B-Cell Lymphoma Lead to an Altered Gene Expression Profile and Changes in Tumor Microenvironment Composition Blood. 132: 669-669. DOI: 10.1182/Blood-2018-99-110473 |
0.514 |
|
| 2017 |
Alcaide M, Yu S, Davidson J, Albuquerque M, Bushell K, Fornika D, Arthur S, Grande BM, McNamara S, Tertre MCD, Batist G, Huntsman DG, Cavallone L, Aguilar A, Basik M, ... ... Morin RD, et al. Targeted error-suppressed quantification of circulating tumor DNA using semi-degenerate barcoded adapters and biotinylated baits. Scientific Reports. 7: 10574. PMID 28874686 DOI: 10.1038/S41598-017-10269-2 |
0.792 |
|
| 2017 |
Nielsen JS, Chang AR, Wick DA, Sedgwick CG, Zong Z, Mungall AJ, Martin SD, Kinloch NN, Ott-Langer S, Brumme ZL, Treon SP, Connors JM, Gascoyne RD, Webb JR, Berry BR, ... Morin RD, et al. Mapping the human T cell repertoire to recurrent driver mutations in MYD88 and EZH2 in lymphoma. Oncoimmunology. 6: e1321184. PMID 28811957 DOI: 10.1080/2162402X.2017.1321184 |
0.377 |
|
| 2017 |
Dewar LJ, Alcaide M, Fornika D, D'Amato L, Shafaatalab S, Stevens CM, Balachandra T, Phillips SM, Sanatani S, Morin RD, Tibbits GF. Investigating the Genetic Causes of Sudden Unexpected Death in Children Through Targeted Next-Generation Sequencing Analysis. Circulation. Cardiovascular Genetics. 10. PMID 28807990 DOI: 10.1161/Circgenetics.116.001738 |
0.69 |
|
| 2017 |
Taghiyar MJ, Rosner J, Grewal D, Grande BM, Aniba R, Grewal J, Boutros PC, Morin RD, Bashashati A, Shah SP. Kronos: a workflow assembler for genome analytics and informatics. Gigascience. PMID 28655203 DOI: 10.1093/Gigascience/Gix042 |
0.718 |
|
| 2017 |
Ennishi D, Mottok A, Ben-Neriah S, Shulha HP, Farinha P, Chan FC, Meissner B, Boyle M, Hother C, Kridel R, Lai D, Saberi S, Bashashati A, Shah SP, Morin RD, et al. Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell of origin-specific clinical impact. Blood. PMID 28351934 DOI: 10.1182/Blood-2016-11-747022 |
0.591 |
|
| 2017 |
Albuquerque MA, Grande BM, Ritch EJ, Pararajalingam P, Jessa S, Krzywinski M, Grewal JK, Shah SP, Boutros PC, Morin RD. Enhancing Knowledge Discovery from Cancer Genomics Data with Galaxy. Gigascience. PMID 28327945 DOI: 10.1093/Gigascience/Gix015 |
0.766 |
|
| 2017 |
Grande BM, Gerhard DS, Griner NB, Casper C, Namirembe C, Omoding A, Orem J, Mbulaiteye SM, Mullighan CG, Sandlund JT, Alexander T, Choi JK, Abramson JS, Gross TG, Noy A, ... ... Morin RD, et al. Burkitt Lymphoma Genome Sequencing Project (BLGSP): Integrative Genomic and Transcriptomic Characterization of Burkitt Lymphoma Blood. 130: 39-39. DOI: 10.1182/Blood.V130.Suppl_1.39.39 |
0.843 |
|
| 2017 |
Arthur SE, Mottok A, Alcaide M, Rushton C, Grande BM, Ennishi D, Davidson J, Bushell KR, Gascoyne RD, Marra MA, Connors JM, Morin GB, Scott DW, Steidl C, Morin RD. Functional Investigation of the Gene NFKBIZ and the Impact of 3'UTR Mutations in Diffuse Large B-Cell Lymphoma Blood. 130: 1228-1228. DOI: 10.1182/Blood.V130.Suppl_1.1228.1228 |
0.827 |
|
| 2017 |
Gambaro K, Marques M, Morin R, Kleinman C, Witcher M, Turcotte S, Samson B, Lespérance B, Ko Y, Dalfen R, St-Hilaire E, Sideris L, Couture F, Tejpar S, Burkes R, et al. Abstract 2795: Integrating multiomics discovery approaches to identify biomarkers of therapeutic resistance in metastatic colorectal cancer through analyses of multiple sequential tumor and liquid biopsies; Qcroc01: NCT00984048 Cancer Research. 77: 2795-2795. DOI: 10.1158/1538-7445.Am2017-2795 |
0.437 |
|
| 2017 |
Wever CM, Lemaire M, Vinh DC, Hébert J, Riazalhosseini Y, Morin R, Johnson NA. Abstract 2447: The mutational landscape of chemo-refractory Burkitt lymphoma Cancer Research. 77: 2447-2447. DOI: 10.1158/1538-7445.Am2017-2447 |
0.461 |
|
| 2017 |
Ennishi D, Bashashati A, Saberi S, Mottok A, Meissner B, Boyle M, Ben-Neriah S, Kridel R, Savage KJ, Sehn LH, Connors JM, Morin RD, Marra MA, Shah SP, Steidl C, et al. Abstract 2445: Integrative genetic analysis identifies therapeutic relevance of cell of origin-specific genetic alterations in diffuse large B-cell lymphoma Cancer Research. 77: 2445-2445. DOI: 10.1158/1538-7445.Am2017-2445 |
0.625 |
|
| 2017 |
Wang Y, Ho C, Bushell K, Vandt S, Bosdet I, Swanson L, Laskin J, Sun S, Melosky B, Murray N, Morin R, Karsan A, Kennecke H. P1.02-011 Comparison of EGFR and KRAS Mutations in Archival Tissue and Circulating Tumor DNA: The Impact of Tumor Heterogeneity Journal of Thoracic Oncology. 12: S493. DOI: 10.1016/J.Jtho.2016.11.594 |
0.736 |
|
| 2017 |
Blakemore S, Daigle S, McDonald A, Morschhauser F, Ribrag V, Salles G, McKay P, Tilly H, Schmitt A, Le Gouill S, Fruchart C, Radford J, Zinzani P, Assouline S, Cartron G, ... ... Morin R, et al. PRELIMINARY EVIDENCE OF A MOLECULAR PREDICTOR OF TAZEMETOSTAT RESPONSE, BEYOND EZH2 MUTATION, IN NHL PATIENTS VIA CHARACTERIZATION OF ARCHIVE TUMOR AND CIRCULATING TUMOR DNA Hematological Oncology. 35: 159-160. DOI: 10.1002/Hon.2438_14 |
0.432 |
|
| 2016 |
Kridel R, Chan FC, Mottok A, Boyle M, Farinha P, Tan K, Meissner B, Bashashati A, McPherson A, Roth A, Shumansky K, Yap D, Ben-Neriah S, Rosner J, Smith MA, ... ... Morin RD, et al. Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study. Plos Medicine. 13: e1002197. PMID 27959929 DOI: 10.1371/Journal.Pmed.1002197 |
0.568 |
|
| 2016 |
Jensen VL, Carter S, Sanders AA, Li C, Kennedy J, Timbers TA, Cai J, Scheidel N, Kennedy BN, Morin RD, Leroux MR, Blacque OE. Whole-Organism Developmental Expression Profiling Identifies RAB-28 as a Novel Ciliary GTPase Associated with the BBSome and Intraflagellar Transport. Plos Genetics. 12: e1006469. PMID 27930654 DOI: 10.1371/Journal.Pgen.1006469 |
0.323 |
|
| 2016 |
Färkkilä A, McConechy MK, Yang W, Talhouk A, Ng Y, Lum A, Morin RD, Bushell K, Riska A, McAlpine JN, Gilks CB, Unkila-Kallio L, Anttonen M, Huntsman DG. FOXL2 402C>G Mutation Can Be Identified in the Circulating Tumor DNA of Patients with Adult Granulosa Cell Tumors. The Journal of Molecular Diagnostics : Jmd. PMID 27810330 DOI: 10.1016/J.Jmoldx.2016.08.005 |
0.832 |
|
| 2016 |
Lowes LE, Bratman SV, Dittamore R, Done S, Kelley SO, Mai S, Morin RD, Wyatt AW, Allan AL. Circulating Tumor Cells (CTC) and Cell-Free DNA (cfDNA) Workshop 2016: Scientific Opportunities and Logistics for Cancer Clinical Trial Incorporation. International Journal of Molecular Sciences. 17. PMID 27618023 DOI: 10.3390/Ijms17091505 |
0.362 |
|
| 2016 |
Alcaide M, Yu S, Bushell K, Fornika D, Nielsen JS, Nelson BH, Mann KK, Assouline S, Johnson NA, Morin RD. Multiplex Droplet Digital PCR Quantification of Recurrent Somatic Mutations in Diffuse Large B-Cell and Follicular Lymphoma. Clinical Chemistry. PMID 27440511 DOI: 10.1373/Clinchem.2016.255315 |
0.83 |
|
| 2016 |
Volik S, Alcaide M, Morin RD, Collins CC. Cell-free DNA (cfDNA): clinical significance and utility in cancer shaped by emerging technologies. Molecular Cancer Research : McR. PMID 27422709 DOI: 10.1158/1541-7786.Mcr-16-0044 |
0.751 |
|
| 2016 |
Vallois D, Dobay MP, Morin RD, Lemonnier F, Missiaglia E, Juilland M, Iwaszkiewicz J, Fataccioli V, Bisig B, Roberti A, Grewal J, Bruneau J, Fabiani B, Martin A, Bonnet C, et al. Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas. Blood. PMID 27369867 DOI: 10.1182/Blood-2016-02-698977 |
0.465 |
|
| 2016 |
Chong LC, Twa DD, Mottok A, Ben-Neriah S, Woolcock BW, Zhao Y, Savage KJ, Marra MA, Scott DW, Gascoyne RD, Morin RD, Mungall AJ, Steidl C. Comprehensive characterization of programmed death ligand structural rearrangements in B-cell non-Hodgkin lymphomas. Blood. PMID 27268263 DOI: 10.1182/Blood-2015-11-683003 |
0.543 |
|
| 2016 |
Wu C, de Miranda NF, Chen L, Wasik AM, Mansouri L, Jurczak W, Galazka K, Dlugosz-Danecka M, Machaczka M, Zhang H, Peng R, Morin RD, Rosenquist R, Sander B, Pan-Hammarström Q. Genetic heterogeneity in primary and relapsed mantle cell lymphomas: Impact of recurrent CARD11 mutations. Oncotarget. PMID 27224912 DOI: 10.18632/Oncotarget.9500 |
0.504 |
|
| 2016 |
Assouline SE, Nielsen TH, Yu S, Alcaide M, Chong L, MacDonald D, Tosikyan A, Kukreti V, Kezouh A, Petrogiannis-Haliotis T, Albuquerque M, Fornika D, Alamouti S, Froment R, Greenwood CM, ... ... Morin RD, et al. Phase 2 study of panobinostat +/- rituximab in relapsed diffuse large B cell lymphoma and biomarkers predictive of response. Blood. PMID 27166360 DOI: 10.1182/Blood-2016-02-699520 |
0.835 |
|
| 2016 |
Wong H, Bushell K, Karasinska J, Arthur S, Morin R, Schaeffer DF, Renouf DJ. Clinical utility of circulating tumor DNA (ctDNA) in resectable pancreatic ductal adenocarcinoma (PDAC). Journal of Clinical Oncology. 34: 247-247. DOI: 10.1200/Jco.2016.34.4_Suppl.247 |
0.817 |
|
| 2016 |
Kennecke HF, Bushell K, McGahan CE, Vandt SA, Loree JM, Bosdet I, Swanson L, Starks L, Davidson J, Tan C, McGhie JP, Johal B, Taylor SK, Zulfiqar M, Laskin JJ, ... ... Morin R, et al. Genotype concordance between archival tumor DNA (atDNA) and circulating tumor DNA (ctDNA) in advanced solid malignancies: The Oncopanel Pilot study. Journal of Clinical Oncology. 34: 1582-1582. DOI: 10.1200/Jco.2016.34.15_Suppl.1582 |
0.804 |
|
| 2016 |
Ennishi D, Bashashati A, Saberi S, Mottok A, Meissner B, Boyle M, Ben-Neriah S, Kridel R, Dominguez-Sola D, Savage KJ, Sehn LH, Connors JM, Morin RD, Marra MA, Shah SP, et al. Frequent Genetic Alterations of PI3K-AKT Pathway and Their Clinical Significance in Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Blood. 128: 607-607. DOI: 10.1182/Blood.V128.22.607.607 |
0.594 |
|
| 2016 |
Kridel R, Chan FC, Mottok A, Boyle M, Farinha P, Tan K, Meissner B, Bashashati A, Ben-Neriah S, Gine E, Ennishi D, Mungall AJ, Morin RD, Johnson NA, Sehn LH, et al. Targeted Sequencing Reveals Novel Gene Mutations Associated with Transformation and Early Progression in Follicular Lymphoma Blood. 128: 2919-2919. DOI: 10.1182/Blood.V128.22.2919.2919 |
0.604 |
|
| 2016 |
Gerhard DS, Grande B, Griner N, Casper C, Gerdts SE, Omoding A, Orem J, Mbulaiteye SM, Ogwang MD, Reynolds SJ, Bhatia K, Ayers L, Choi JK, Mullighan CG, Sandlund JT, ... ... Morin RD, et al. Burkitt Lymphoma Genome Sequencing Project (BLGSP): Introduction Blood. 128: 1760-1760. DOI: 10.1182/Blood.V128.22.1760.1760 |
0.824 |
|
| 2016 |
Chan FC, Kridel R, Mottok A, Boyle M, Farinha P, Tan K, Meissner B, Bashashati A, McPherson A, Roth A, Shumansky K, Yap D, Ben-Neriah S, Rosner J, Smith MA, ... ... Morin RD, et al. Divergent Modes of Tumor Evolution Underlie Histological Transformation and Early Progression of Follicular Lymphoma Blood. 128: 1091-1091. DOI: 10.1182/Blood.V128.22.1091.1091 |
0.592 |
|
| 2016 |
Färkkilä A, McConechy MK, Yang W, Talhouk A, Ng Y, Morin R, Riska A, McAlpine JN, Unkila-Kallio L, Anttonen M, Huntsman DG. Abstract B10: FOXL2 402C>G mutation can be identified in the circulating tumor DNA of patients with adult-type granulosa cell tumor. Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Ovca15-B10 |
0.49 |
|
| 2016 |
Johnson N, Assouline S, Alcaide M, Mohajeri A, Greenwood C, Riazalhosseini Y, Mann K, Morin R. Abstract 117: Genetic landscapes of relapsed and refractory diffuse large B cell lymphomas Cancer Research. 76: 117-117. DOI: 10.1158/1538-7445.Am2016-117 |
0.563 |
|
| 2015 |
Morin RD, Assouline SE, Alcaide M, Mohajeri A, Johnston RL, Chong L, Grewal J, Yu S, Fornika D, Bushell K, Holm Nielsen T, Petrogiannis-Haliotis T, Crump M, Tosikyan A, Grande BM, et al. Genetic landscapes of relapsed and refractory diffuse large B cell lymphomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26647218 DOI: 10.1158/1078-0432.Ccr-15-2123 |
0.805 |
|
| 2015 |
Nielsen JS, Sedgwick C, Shahid A, Zong Z, Brumme ZL, Yu S, Liu L, Kroeger DR, Treon SP, Connors JM, Gascoyne RD, Berry BR, Marra MA, Morin RD, Macpherson N, et al. Toward personalized lymphoma immunotherapy: Identification of common driver mutations recognized by patient CD8+ T cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26631611 DOI: 10.1158/1078-0432.Ccr-15-2023 |
0.786 |
|
| 2015 |
Lebovitz CB, Robertson AG, Goya R, Jones SJ, Morin RD, Marra MA, Gorski SM. Cross-cancer profiling of molecular alterations within the human autophagy interaction network. Autophagy. 0. PMID 26208877 DOI: 10.1080/15548627.2015.1067362 |
0.803 |
|
| 2015 |
Lim EL, Trinh DL, Scott DW, Chu A, Krzywinski M, Zhao Y, Robertson AG, Mungall AJ, Schein J, Boyle M, Mottok A, Ennishi D, Johnson NA, Steidl C, Connors JM, ... Morin RD, et al. Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients. Genome Biology. 16: 18. PMID 25723320 DOI: 10.1186/S13059-014-0568-Y |
0.529 |
|
| 2015 |
Twa DD, Mottok A, Chan FC, Ben-Neriah S, Woolcock BW, Tan KL, Mungall AJ, McDonald H, Zhao Y, Lim RS, Nelson BH, Milne K, Shah SP, Morin RD, Marra MA, et al. Recurrent genomic rearrangements in primary testicular lymphoma. The Journal of Pathology. 236: 136-41. PMID 25712539 DOI: 10.1002/Path.4522 |
0.567 |
|
| 2015 |
Bushell KR, Kim Y, Chan FC, Ben-Neriah S, Jenks A, Alcaide M, Fornika D, Grande BM, Arthur S, Gascoyne RD, Steidl C, Morin RD. Genetic inactivation of TRAF3 in canine and human B-cell lymphoma. Blood. 125: 999-1005. PMID 25468570 DOI: 10.1182/Blood-2014-10-602714 |
0.841 |
|
| 2015 |
Chan FC, Telenius A, Healy S, Ben-Neriah S, Mottok A, Lim R, Drake M, Hu S, Ding J, Ha G, Scott DW, Kridel R, Bashashati A, Rogic S, Johnson N, ... Morin RD, et al. An RCOR1 loss-associated gene expression signature identifies a prognostically significant DLBCL subgroup. Blood. 125: 959-66. PMID 25395426 DOI: 10.1182/Blood-2013-06-507152 |
0.587 |
|
| 2015 |
Nielsen JS, Chang AR, Wick DA, Sedgwick CG, Zong Z, Mungall AJ, Baraki B, Kinloch N, Brumme ZL, Treon SP, Connors JM, Gascoyne RD, Webb JR, Berry BR, Morin RD, et al. Immunogenicity of recurrent mutations in MYD88 and EZH2 in non-Hodgkin lymphomas Journal For Immunotherapy of Cancer. 3. DOI: 10.1186/2051-1426-3-S2-P386 |
0.434 |
|
| 2015 |
Assouline S, Crump M, Holm Nielsen T, Alcaide M, Macdonald D, Tosikyan A, Haliotis T, Greenwood C, Klein Oros K, Morin R, Johnson N, Mann KK. A Randomized, Phase II Study with Biomarker Analysis of Panobinostat with or without Rituximab in Relapsed Diffuse Large B Cell Lymphoma Blood. 126: 2719-2719. DOI: 10.1182/Blood.V126.23.2719.2719 |
0.481 |
|
| 2015 |
Ennishi D, Mottok A, Shulha H, Farinha P, Chan FC, Meissner B, Boyle M, Ben-Neriah S, Hother CE, Kridel R, Morin R, Marra MA, Savage KJ, Sehn LH, Connors JM, et al. Genetic Alterations of Gα13 Signaling Pathway with BCL2 over-Expression Confers Lymphoma Dissemination and Inferior Outcome in Germinal Center B Cell Diffuse Large B Cell Lymphoma Blood. 126: 111-111. DOI: 10.1182/Blood.V126.23.111.111 |
0.616 |
|
| 2015 |
Ennishi D, Mottok A, Savage KJ, Ben-Neriah S, Shulha H, Farinha P, Chan FC, Meissner B, Boyle M, Hother CE, Kridel R, Morin R, Marra MA, Sehn LH, Steidl C, et al. Comprehensive MYC and BCL2 Genetic Profiling in De Novo Diffuse Large B-Cell Lymphoma Demonstrates Clinically Relevant Genetic Alterations According to Cell of Origin Subtype Blood. 126: 109-109. DOI: 10.1182/Blood.V126.23.109.109 |
0.596 |
|
| 2015 |
McNamara S, Morin R, Tertre MCd, McCloskey R, Johnston R, Fornika D, Samson B, Lespérance B, Alcindor T, Ko Y, Dalfen R, St-Hilaire E, Sideris L, Couture F, Prenen H, et al. Abstract 3888: Molecular profiling of sequential biopsies in patients with metastatic colorectal cancer identifies genomic alterations that evolve during first-line therapy and could have therapeutic implications: A prospective study to identify molecular mechanisms of clinical resistance (QCROC-01: NCT00984048). Cancer Research. 75: 3888-3888. DOI: 10.1158/1538-7445.Am2015-3888 |
0.436 |
|
| 2014 |
Nielsen TH, Diaz Z, Christodoulopoulos R, Charbonneau F, Qureshi S, Rousseau C, Benlimame N, Camlioglu E, Constantin AM, Oros KK, Krumsiek J, Crump M, Morin RD, Cerchietti L, Johnson NA, et al. Methods for sample acquisition and processing of serial blood and tumor biopsies for multicenter diffuse large B-cell lymphoma clinical trials. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 2688-93. PMID 25472678 DOI: 10.1158/1055-9965.Epi-14-0549 |
0.425 |
|
| 2014 |
Berg T, Thoene S, Yap D, Wee T, Schoeler N, Rosten P, Lim E, Bilenky M, Mungall AJ, Oellerich T, Lee S, Lai CK, Umlandt P, Salmi A, Chang H, ... ... Morin RD, et al. A transgenic mouse model demonstrating the oncogenic role of mutations in the polycomb-group gene EZH2 in lymphomagenesis. Blood. 123: 3914-24. PMID 24802772 DOI: 10.1182/Blood-2012-12-473439 |
0.615 |
|
| 2014 |
Chambwe N, Kormaksson M, Geng H, De S, Michor F, Johnson NA, Morin RD, Scott DW, Godley LA, Gascoyne RD, Melnick A, Campagne F, Shaknovich R. Variability in DNA methylation defines novel epigenetic subgroups of DLBCL associated with different clinical outcomes. Blood. 123: 1699-708. PMID 24385541 DOI: 10.1182/Blood-2013-07-509885 |
0.374 |
|
| 2014 |
Ennishi D, Hoffer C, Shulha H, Mottok A, Farinha P, Chan FC, Meissner B, Boyle M, Ben-Neriah S, Morin RD, Marra MA, Savage KJ, Sehn LH, Connors JM, Steidl C, et al. Clinical Significance of Genetic Aberrations in Diffuse Large B Cell Lymphoma Blood. 124: 703-703. DOI: 10.1182/Blood.V124.21.703.703 |
0.668 |
|
| 2014 |
Totten S, Gaucher D, Morin RD, Assouline S, Connors JM, Marra MA, Scott DW, Gascoyne RD, Pelletier J, Mann KK, Johnson N. FAS Mutations Accelerate Lymphoma Growth and Induce Therapeutic Resistance Blood. 124: 3018-3018. DOI: 10.1182/Blood.V124.21.3018.3018 |
0.584 |
|
| 2014 |
Johnson N, Gaucher D, Morin R, Gascoyne R, Connors J, Marra M, Pelletier J, Rigsby H, Mann K. Abstract 959: FAS mutations induce therapeutic resistance in non-Hodgkin lymphomas Cancer Research. 74: 959-959. DOI: 10.1158/1538-7445.Am2014-959 |
0.563 |
|
| 2013 |
Morin RD, Gascoyne RD. Newly identified mechanisms in B-cell non-Hodgkin lymphomas uncovered by next-generation sequencing. Seminars in Hematology. 50: 303-13. PMID 24246698 DOI: 10.1053/J.Seminhematol.2013.09.004 |
0.477 |
|
| 2013 |
Morin RD, Mungall K, Pleasance E, Mungall AJ, Goya R, Huff RD, Scott DW, Ding J, Roth A, Chiu R, Corbett RD, Chan FC, Mendez-Lago M, Trinh DL, Bolger-Munro M, et al. Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing. Blood. 122: 1256-65. PMID 23699601 DOI: 10.1182/Blood-2013-02-483727 |
0.858 |
|
| 2013 |
Trinh DL, Scott DW, Morin RD, Mendez-Lago M, An J, Jones SJ, Mungall AJ, Zhao Y, Schein J, Steidl C, Connors JM, Gascoyne RD, Marra MA. Analysis of FOXO1 mutations in diffuse large B-cell lymphoma. Blood. 121: 3666-74. PMID 23460611 DOI: 10.1182/Blood-2013-01-479865 |
0.624 |
|
| 2013 |
Griffith M, Mwenifumbo JC, Cheung PY, Paul JE, Pugh TJ, Tang MJ, Chittaranjan S, Morin RD, Asano JK, Ally AA, Miao L, Lee A, Chan SY, Taylor G, Severson T, et al. Novel mRNA isoforms and mutations of uridine monophosphate synthetase and 5-fluorouracil resistance in colorectal cancer. The Pharmacogenomics Journal. 13: 148-58. PMID 22249354 DOI: 10.1038/Tpj.2011.65 |
0.751 |
|
| 2013 |
Ennishi D, Chan FC, Scott DW, Hother C, Meissner B, Boyle M, Morin RD, Sehn LH, Marra MA, Connors JM, Steidl C, Gascoyne RD. Genetic Alterations In Immune Cell Crosstalk Genes In Diffuse Large B-Cell Lymphoma Predict Survival Blood. 122: 500-500. DOI: 10.1182/Blood.V122.21.500.500 |
0.6 |
|
| 2013 |
Berg T, Thoene S, Yap D, Wee T, Schoeler N, Rosten P, Lim E, Bilenky M, Mungall AJ, Oellerich T, Umlandt P, Salmi A, Chang H, Yue L, Lai D, ... ... Morin RD, et al. Characterization Of The Effects Of Mutated EZH2 On Expression and Epigenome In a Mouse Lymphoma Model Blood. 122: 346-346. DOI: 10.1182/Blood.V122.21.346.346 |
0.614 |
|
| 2013 |
Nielsen TH, Diaz Z, Christodoulopoulos R, Yao L, Qureshi S, Benlimame N, Camlioglu E, Crump M, Morin RD, Johnson N, Haliotis TP, Miller WH, Assouline S, Mann KK. Abstract 64: Quality and feasibility of a protocol for simultaneous isolation of RNA, DNA and tissue for IHC from needle core lymph node biopsies in DLBCL adapted for multi-center trials. Cancer Research. 73: 64-64. DOI: 10.1158/1538-7445.Am2013-64 |
0.38 |
|
| 2013 |
Huff RD, Mendez-Lago M, Morin RD, Scott DW, Connors JM, Gascoyne RD, Marra MM. Abstract A10: MLL2 interactions in follicular and diffuse large B-cell lymphoma Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Pms-A10 |
0.542 |
|
| 2013 |
Yakovenko O, Morin R, Vashchenko G, Jones SJM. Theoretical Investigation of the D83V Mutation within the Myocyte-Specific Enhancer Factor-2 Beta and Its Role in Cancer Journal of Theoretical Chemistry. 2013: 1-10. DOI: 10.1155/2013/313419 |
0.334 |
|
| 2013 |
Morin RD, Marra M. Transcriptomics in the Age of Ultra High-Throughput Sequencing Genomic and Personalized Medicine. 1: 145-154. DOI: 10.1016/B978-0-12-382227-7.00012-4 |
0.353 |
|
| 2012 |
Khodabakhshi AH, Morin RD, Fejes AP, Mungall AJ, Mungall KL, Bolger-Munro M, Johnson NA, Connors JM, Gascoyne RD, Marra MA, Birol I, Jones SJM. Recurrent targets of aberrant somatic hypermutation in lymphoma Oncotarget. 3: 1308-1319. PMID 23131835 DOI: 10.18632/Oncotarget.653 |
0.569 |
|
| 2012 |
Roberts KG, Morin RD, Zhang J, Hirst M, Zhao Y, Su X, Chen SC, Payne-Turner D, Churchman ML, Harvey RC, Chen X, Kasap C, Yan C, Becksfort J, Finney RP, et al. Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. Cancer Cell. 22: 153-66. PMID 22897847 DOI: 10.1016/J.Ccr.2012.06.005 |
0.538 |
|
| 2012 |
Scott DW, Mungall KL, Ben-Neriah S, Rogic S, Morin RD, Slack GW, Tan KL, Chan FC, Lim RS, Connors JM, Marra MA, Mungall AJ, Steidl C, Gascoyne RD. TBL1XR1/TP63: a novel recurrent gene fusion in B-cell non-Hodgkin lymphoma. Blood. 119: 4949-52. PMID 22496164 DOI: 10.1182/Blood-2012-02-414441 |
0.603 |
|
| 2012 |
Roth A, Ding J, Morin R, Crisan A, Ha G, Giuliany R, Bashashati A, Hirst M, Turashvili G, Oloumi A, Marra MA, Aparicio S, Shah SP. JointSNVMix: a probabilistic model for accurate detection of somatic mutations in normal/tumour paired next-generation sequencing data. Bioinformatics (Oxford, England). 28: 907-13. PMID 22285562 DOI: 10.1093/Bioinformatics/Bts053 |
0.582 |
|
| 2012 |
Kridel R, Meissner B, Rogic S, Boyle M, Telenius A, Woolcock B, Gunawardana J, Jenkins C, Cochrane C, Ben-Neriah S, Tan K, Morin RD, Opat S, Sehn LH, Connors JM, et al. Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma. Blood. 119: 1963-71. PMID 22210878 DOI: 10.1182/Blood-2011-11-391474 |
0.623 |
|
| 2012 |
Schuetz JM, Johnson NA, Morin RD, Scott DW, Tan K, Ben-Nierah S, Boyle M, Slack GW, Marra MA, Connors JM, Brooks-Wilson AR, Gascoyne RD. BCL2 mutations in diffuse large B-cell lymphoma. Leukemia. 26: 1383-90. PMID 22189900 DOI: 10.1038/Leu.2011.378 |
0.642 |
|
| 2012 |
Chan FC, Ben-Neriah S, Lim R, Hu S, Rogic S, Johnson N, Morin RD, Ha G, Ding J, Scott DW, Sehn LH, Connors JM, Marra MA, Gascoyne RD, Shah SP, et al. Large-Scale High Resolution Integration of Copy Number and Gene Expression in DLBCL Reveals Focal and Frequent Deletions in Chromatin Modifying Genes with Outcome Correlation Blood. 120: 295-295. DOI: 10.1182/Blood.V120.21.295.295 |
0.565 |
|
| 2012 |
Johnson N, Gaucher D, Rigsby H, Morin RD, Connors JM, Marra M, Gascoyne RD. FAS Mutations Are Associated with Therapeutic Resistance in Follicular Lymphoma Blood. 120: 1549-1549. DOI: 10.1182/Blood.V120.21.1549.1549 |
0.609 |
|
| 2012 |
Mendez-Lago M, Morin R, Mungall A, Goya R, Trinh D, Corbett R, Rogic S, Gascoyne R, Connors J, Marra M. 567 Genomic Analysis of Non-Hodgkin Lymphomas Reveals Mutations in Chromatin Remodelling Genes European Journal of Cancer. 48: S135. DOI: 10.1016/S0959-8049(12)71226-1 |
0.821 |
|
| 2011 |
Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD, Johnson NA, Severson TM, Chiu R, Field M, Jackman S, Krzywinski M, Scott DW, Trinh DL, Tamura-Wells J, et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma Nature. 476: 298-303. PMID 21796119 DOI: 10.1038/Nature10351 |
0.842 |
|
| 2011 |
Kuchenbauer F, Mah SM, Heuser M, McPherson A, Rüschmann J, Rouhi A, Berg T, Bullinger L, Argiropoulos B, Morin RD, Lai D, Starczynowski DT, Karsan A, Eaves CJ, Watahiki A, et al. Comprehensive analysis of mammalian miRNA* species and their role in myeloid cells. Blood. 118: 3350-8. PMID 21628414 DOI: 10.1182/Blood-2010-10-312454 |
0.414 |
|
| 2011 |
Yap DB, Chu J, Berg T, Schapira M, Cheng SW, Moradian A, Morin RD, Mungall AJ, Meissner B, Boyle M, Marquez VE, Marra MA, Gascoyne RD, Humphries RK, Arrowsmith CH, et al. Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation. Blood. 117: 2451-9. PMID 21190999 DOI: 10.1182/Blood-2010-11-321208 |
0.58 |
|
| 2011 |
Starczynowski DT, Morin R, McPherson A, Lam J, Chari R, Wegrzyn J, Kuchenbauer F, Hirst M, Tohyama K, Humphries RK, Lam WL, Marra M, Karsan A. Genome-wide identification of human microRNAs located in leukemia-associated genomic alterations. Blood. 117: 595-607. PMID 20962326 DOI: 10.1182/Blood-2010-03-277012 |
0.457 |
|
| 2011 |
Roberts KG, Morin RD, Zhang J, Hirst M, Harvey RC, Kasap C, Chen X, Edmonson M, Chen I, Shah N, Devidas M, Reaman GH, Smith MA, Pui C, Downing JR, et al. Novel Chromosomal Rearrangements and Sequence Mutations in High-Risk Ph-Like Acute Lymphoblastic Leukemia Blood. 118: 67-67. DOI: 10.1182/Blood.V118.21.67.67 |
0.592 |
|
| 2011 |
Berg T, Yap D, Thoene S, Wee T, Schoeler N, Umlandt P, Chang H, Yue L, Lai D, Cheng G, Morin RD, Hirst M, Marra MA, Morin GB, Gascoyne RD, et al. Mutated EZH2 Collaborates with Myc in Inducing Lymphoma in a Mouse Model Blood. 118: 227-227. DOI: 10.1182/Blood.V118.21.227.227 |
0.581 |
|
| 2010 |
McLarren KW, Severson TM, du Souich C, Stockton DW, Kratz LE, Cunningham D, Hendson G, Morin RD, Wu D, Paul JE, An J, Nelson TN, Chou A, DeBarber AE, Merkens LS, et al. Hypomorphic temperature-sensitive alleles of NSDHL cause CK syndrome. American Journal of Human Genetics. 87: 905-14. PMID 21129721 DOI: 10.1016/J.Ajhg.2010.11.004 |
0.479 |
|
| 2010 |
Cerchietti LC, Hatzi K, Caldas-Lopes E, Yang SN, Figueroa ME, Morin RD, Hirst M, Mendez L, Shaknovich R, Cole PA, Bhalla K, Gascoyne RD, Marra M, Chiosis G, Melnick A. BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy. The Journal of Clinical Investigation. 120: 4569-82. PMID 21041953 DOI: 10.1172/Jci42869 |
0.551 |
|
| 2010 |
Cheung KJ, Johnson NA, Affleck JG, Severson T, Steidl C, Ben-Neriah S, Schein J, Morin RD, Moore R, Shah SP, Qian H, Paul JE, Telenius A, Relander T, Lam W, et al. Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis. Cancer Research. 70: 9166-74. PMID 20884631 DOI: 10.1158/0008-5472.Can-10-2460 |
0.601 |
|
| 2010 |
Griffith M, Griffith OL, Mwenifumbo J, Goya R, Morrissy AS, Morin RD, Corbett R, Tang MJ, Hou YC, Pugh TJ, Robertson G, Chittaranjan S, Ally A, Asano JK, Chan SY, et al. Alternative expression analysis by RNA sequencing. Nature Methods. 7: 843-7. PMID 20835245 DOI: 10.1038/Nmeth.1503 |
0.795 |
|
| 2010 |
Jones SJ, Laskin J, Li YY, Griffith OL, An J, Bilenky M, Butterfield YS, Cezard T, Chuah E, Corbett R, Fejes AP, Griffith M, Yee J, Martin M, Mayo M, ... ... Morin RD, et al. Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors. Genome Biology. 11: R82. PMID 20696054 DOI: 10.1186/Gb-2010-11-8-R82 |
0.716 |
|
| 2010 |
Morin RD, Zhao Y, Prabhu AL, Dhalla N, McDonald H, Pandoh P, Tam A, Zeng T, Hirst M, Marra M. Preparation and analysis of microRNA libraries using the Illumina massively parallel sequencing technology. Methods in Molecular Biology (Clifton, N.J.). 650: 173-99. PMID 20686952 DOI: 10.1007/978-1-60761-769-3_14 |
0.487 |
|
| 2010 |
Morozova O, Vojvodic M, Grinshtein N, Hansford LM, Blakely KM, Maslova A, Hirst M, Cezard T, Morin RD, Moore R, Smith KM, Miller F, Taylor P, Thiessen N, Varhol R, et al. System-level analysis of neuroblastoma tumor-initiating cells implicates AURKB as a novel drug target for neuroblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 4572-82. PMID 20651058 DOI: 10.1158/1078-0432.Ccr-10-0627 |
0.773 |
|
| 2010 |
Ahn HW, Morin RD, Zhao H, Harris RA, Coarfa C, Chen ZJ, Milosavljevic A, Marra MA, Rajkovic A. MicroRNA transcriptome in the newborn mouse ovaries determined by massive parallel sequencing. Molecular Human Reproduction. 16: 463-71. PMID 20215419 DOI: 10.1093/Molehr/Gaq017 |
0.442 |
|
| 2010 |
Goya R, Sun MG, Morin RD, Leung G, Ha G, Wiegand KC, Senz J, Crisan A, Marra MA, Hirst M, Huntsman D, Murphy KP, Aparicio S, Shah SP. SNVMix: predicting single nucleotide variants from next-generation sequencing of tumors. Bioinformatics (Oxford, England). 26: 730-6. PMID 20130035 DOI: 10.1093/Bioinformatics/Btq040 |
0.801 |
|
| 2010 |
Morin RD, Johnson NA, Severson TM, Mungall AJ, An J, Goya R, Paul JE, Boyle M, Woolcock BW, Kuchenbauer F, Yap D, Humphries RK, Griffith OL, Shah S, Zhu H, et al. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nature Genetics. 42: 181-5. PMID 20081860 DOI: 10.1038/ng.518 |
0.833 |
|
| 2010 |
Starczynowski DT, Kuchenbauer F, Argiropoulos B, Sung S, Morin R, Muranyi A, Hirst M, Hogge D, Marra M, Wells RA, Buckstein R, Lam W, Humphries RK, Karsan A. Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype. Nature Medicine. 16: 49-58. PMID 19898489 DOI: 10.1038/Nm.2054 |
0.426 |
|
| 2010 |
Jones SJ, Laskin J, Li YY, Griffith OL, An J, Bilenky M, Butterfield YS, Chuah E, Corbett R, Fejes A, Chan S, Liao N, Kasaian K, Griffith M, Yee J, ... ... Morin RD, et al. Personalized oncogenomics Genome Biology. 11: I5. DOI: 10.1186/gb-2010-11-s1-i5 |
0.615 |
|
| 2010 |
Jones SJ, Laskin J, Li YY, Griffith OL, An J, Bilenky M, Butterfield YS, Cezard T, Chuah E, Corbett R, Fejes A, Griffith M, Yee J, Martin M, Mayo M, ... ... Morin RD, et al. Genomic analysis of a rare human tumor Bmc Bioinformatics. 11. DOI: 10.1186/1471-2105-11-S4-O3 |
0.711 |
|
| 2010 |
Morin RD, Mendez-Lago M, Mungall AJ, Johnson NA, Goya R, Severson T, Mungall K, An J, Yakovenko O, Jackman S, Krzywinski M, Griffith M, Chan S, Tam A, Smailus D, et al. Identification of Genes Frequently Mutated In FL and DLBCL with Transcriptome, Genome and Exome Sequencing Blood. 116: 804-804. DOI: 10.1182/Blood.V116.21.804.804 |
0.858 |
|
| 2010 |
Mungall AJ, Morin RD, An J, Yakovenko O, Boyle M, Johnson NA, Woolcock B, Leach S, Mayo M, Mendez-Lago M, Munro S, Zeng T, Zhao Y, Hirst M, Holt RA, et al. Recurrent DNA Mutations In Non-Hodgkin Lymphomas Reveal Candidate Therapeutic Targets Blood. 116: 632-632. DOI: 10.1182/Blood.V116.21.632.632 |
0.658 |
|
| 2010 |
Mendez-Lago M, Morin RD, Mungall AJ, Chan S, Chittaranjan S, Severson T, Goya R, Mungall K, Johnson NA, Boyle M, Woolcock B, Zeng T, McDonald H, An J, Yakovenko O, et al. Mutations In MLL2 and MEF2B Genes In Follicular Lymphoma and Diffuse Large B-Cell Lymphoma Blood. 116: 473-473. DOI: 10.1182/Blood.V116.21.473.473 |
0.854 |
|
| 2010 |
Schuetz JM, Johnson NA, Morin RD, Hirst M, Zhao Y, Tam A, Moore R, Zeng T, Marra MA, Connors JM, Brooks-Wilson AR, Gascoyne RD. BCL2 Is Highly Mutated In Diffuse Large B-Cell Lymphoma Blood. 116: 4187-4187. DOI: 10.1182/Blood.V116.21.4187.4187 |
0.653 |
|
| 2009 |
Shah SP, Morin RD, Khattra J, Prentice L, Pugh T, Burleigh A, Delaney A, Gelmon K, Guliany R, Senz J, Steidl C, Holt RA, Jones S, Sun M, Leung G, et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature. 461: 809-13. PMID 19812674 DOI: 10.1038/Nature08489 |
0.687 |
|
| 2009 |
Temple G, Gerhard DS, Rasooly R, Feingold EA, Good PJ, Robinson C, Mandich A, Derge JG, Lewis J, Shoaf D, Collins FS, Jang W, Wagner L, Shenmen CM, ... ... Morin R, et al. The completion of the Mammalian Gene Collection (MGC). Genome Research. 19: 2324-33. PMID 19767417 DOI: 10.1101/Gr.095976.109 |
0.633 |
|
| 2009 |
Morrissy AS, Morin RD, Delaney A, Zeng T, McDonald H, Jones S, Zhao Y, Hirst M, Marra MA. Next-generation tag sequencing for cancer gene expression profiling. Genome Research. 19: 1825-35. PMID 19541910 DOI: 10.1101/Gr.094482.109 |
0.501 |
|
| 2009 |
Birol I, Jackman SD, Nielsen CB, Qian JQ, Varhol R, Stazyk G, Morin RD, Zhao Y, Hirst M, Schein JE, Horsman DE, Connors JM, Gascoyne RD, Marra MA, Jones SJM. De novo transcriptome assembly with ABySS Bioinformatics. 25: 2872-2877. PMID 19528083 DOI: 10.1093/Bioinformatics/Btp367 |
0.499 |
|
| 2009 |
Shah SP, Köbel M, Senz J, Morin RD, Clarke BA, Wiegand KC, Leung G, Zayed A, Mehl E, Kalloger SE, Sun M, Giuliany R, Yorida E, Jones S, Varhol R, et al. Mutation of FOXL2 in granulosa-cell tumors of the ovary. The New England Journal of Medicine. 360: 2719-29. PMID 19516027 DOI: 10.1056/Nejmoa0902542 |
0.607 |
|
| 2009 |
Mullighan CG, Morin R, Zhang J, Hirst M, Zhao Y, Yan C, Finney R, Edmonson M, Su X, Buetow KE, Carroll WL, Chen I, Devidas M, Gerhard D, Harvey RC, et al. Next Generation Transcriptomic Resequencing Identifies Novel Genetic Alterations in High-Risk (HR) Childhood Acute Lymphoblastic Leukemia (ALL): A Report From the Children's Oncology Group (COG) HR ALL TARGET Project. Blood. 114: 704-704. DOI: 10.1182/Blood.V114.22.704.704 |
0.548 |
|
| 2009 |
Reiman T, Morin R, Goya R, Wong T, Zhao Y, Hirst M, Pilarski LM, Belch A, Marra M. Comparative Whole Transcriptome Shotgun Sequencing (WTSS) of Myeloma at Diagnosis and at Drug-Resistant Relapse. Blood. 114: 603-603. DOI: 10.1182/Blood.V114.22.603.603 |
0.503 |
|
| 2009 |
Johnson NA, Morin R, Severson T, Mungall AJ, Zhao Y, Schein JE, Boyle M, Woolcock B, Moore R, Holt R, Horsman DE, Connors JM, Jones S, Hirst M, Marra MA, et al. FAS Mutations in Follicular Lymphoma Are Rare but Associated with Aggressive Clinical Behavior. Blood. 114: 3967-3967. DOI: 10.1182/Blood.V114.22.3967.3967 |
0.592 |
|
| 2009 |
Kuchenbauer F, Mah SM, McPherson A, Heuser M, Argiropolous B, Morin R, Berg T, Lai D, Muranyi AL, Hogge DE, Ruschmann J, Starczynowski DT, Karsan A, O'Connor M, Eaves CJ, et al. Differential Expression of Mirna* Species in Cancer and the Contribution of MiR-223* to the Development of Acute Myeloid Leukemia. Blood. 114: 2960-2960. DOI: 10.1182/Blood.V114.22.2960.2960 |
0.339 |
|
| 2009 |
Cheung K, Johnson N, Affleck J, Severson T, Steidl C, Ben-Neriah S, Schein J, Morin R, Moore R, Shah SP, Qian H, Paul J, Telenius A, Lai B, Relander T, et al. TNFRSF14 Is Mutated in a Subset of Follicular Lymphoma and Correlated with Inferior Prognosis. Blood. 114: 1919-1919. DOI: 10.1182/Blood.V114.22.1919.1919 |
0.532 |
|
| 2009 |
Morin R, Johnson N, Severson T, Mungall AJ, An J, Paul J, Boyle M, Woolcock B, Kuchenbauer F, Yap D, Humphries RK, Griffith O, Shah SP, Corbett R, Tam A, et al. Tyrosine 641 of the EZH2 Oncogene Is Frequently Mutated in Follicular and Diffuse Large B-Cell Lymphomas of Germinal Center Origin. Blood. 114: 139-139. DOI: 10.1182/Blood.V114.22.139.139 |
0.633 |
|
| 2009 |
Ahn HW, Zhao H, Harris RA, Coarfa C, Milosavljevic A, Morin RD, Marra MA, Rajkovic A. Massive Parallel Sequencing of Small RNAs from Newborn Mouse Ovaries Identifies Novel miRNAs Preferentially Expressed in the Ovaries. Biology of Reproduction. 81: 565-565. DOI: 10.1093/Biolreprod/81.S1.565 |
0.454 |
|
| 2008 |
Kuchenbauer F, Morin RD, Argiropoulos B, Petriv OI, Griffith M, Heuser M, Yung E, Piper J, Delaney A, Prabhu AL, Zhao Y, McDonald H, Zeng T, Hirst M, Hansen CL, et al. In-depth characterization of the microRNA transcriptome in a leukemia progression model. Genome Research. 18: 1787-97. PMID 18849523 DOI: 10.1101/Gr.077578.108 |
0.595 |
|
| 2008 |
Morin R, Bainbridge M, Fejes A, Hirst M, Krzywinski M, Pugh T, McDonald H, Varhol R, Jones S, Marra M. Profiling the HeLa S3 transcriptome using randomly primed cDNA and massively parallel short-read sequencing. Biotechniques. 45: 81-94. PMID 18611170 DOI: 10.2144/000112900 |
0.635 |
|
| 2008 |
Morin RD, O'Connor MD, Griffith M, Kuchenbauer F, Delaney A, Prabhu AL, Zhao Y, McDonald H, Zeng T, Hirst M, Eaves CJ, Marra MA. Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome Research. 18: 610-21. PMID 18285502 DOI: 10.1101/Gr.7179508 |
0.628 |
|
| 2008 |
Griffith M, Tang MJ, Griffith OL, Morin RD, Chan SY, Asano JK, Zeng T, Flibotte S, Ally A, Baross A, Hirst M, Jones SJM, Morin GB, Tai IT, Marra MA. ALEXA: A microarray design platform for alternative expression analysis [3] Nature Methods. 5: 118. PMID 18235430 DOI: 10.1038/Nmeth0208-118 |
0.592 |
|
| 2008 |
Starczynowski DT, Kuchenbauer F, Argiropoulos B, Sung S, Morin R, Muranyi AL, Hirst M, Hogge DE, Marra M, Wells RA, Lam W, Humphries RK, Karsan A. Identification of Mir-145 and Mir-146a as Micrornas Involved in the Pathogenesis of 5q- Syndrome Blood. 112: 853-853. DOI: 10.1182/Blood.V112.11.853.853 |
0.338 |
|
| 2007 |
Hirst M, Delaney A, Rogers SA, Schnerch A, Persaud DR, O'Connor MD, Zeng T, Moksa M, Fichter K, Mah D, Go A, Morin RD, Baross A, Zhao Y, Khattra J, et al. LongSAGE profiling of nine human embryonic stem cell lines. Genome Biology. 8: R113. PMID 17570852 DOI: 10.1186/Gb-2007-8-6-R113 |
0.458 |
|
| 2007 |
Kuchenbauer F, Morin R, Staaf J, Borg A, Agiropoulos B, Delaney A, Zeng T, Mcdonald H, Hirst M, Rovira C, Marra M, Humphries RK. Accurate Detection of the microRNA Transcriptome in a Leukemia Progression Model. Blood. 110: 866-866. DOI: 10.1182/Blood.V110.11.866.866 |
0.432 |
|
| 2006 |
McLeod MP, Warren RL, Hsiao WW, Araki N, Myhre M, Fernandes C, Miyazawa D, Wong W, Lillquist AL, Wang D, Dosanjh M, Hara H, Petrescu A, Morin RD, Yang G, et al. The complete genome of Rhodococcus sp. RHA1 provides insights into a catabolic powerhouse. Proceedings of the National Academy of Sciences of the United States of America. 103: 15582-7. PMID 17030794 DOI: 10.1073/Pnas.0607048103 |
0.489 |
|
| 2006 |
Morin RD, Chang E, Petrescu A, Liao N, Griffith M, Chow W, Kirkpatrick R, Butterfield YS, Young AC, Stott J, Barber S, Babakaiff R, Dickson MC, Matsuo C, Wong D, et al. Sequencing and analysis of 10,967 full-length cDNA clones from Xenopus laevis and Xenopus tropicalis reveals post-tetraploidization transcriptome remodeling. Genome Research. 16: 796-803. PMID 16672307 DOI: 10.1101/Gr.4871006 |
0.618 |
|
| 2005 |
Warren RL, Butterfield YS, Morin RD, Siddiqui AS, Marra MA, Jones SJ. Management and visualization of whole genome shotgun assemblies using SAM. Biotechniques. 38: 715-6, 718, 720. PMID 15945370 DOI: 10.2144/05385St01 |
0.458 |
|
| 2004 |
Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, ... ... Morin R, et al. The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Research. 14: 2121-7. PMID 15489334 DOI: 10.1101/Gr.2596504 |
0.593 |
|
| Show low-probability matches. |